Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI India ETF
INDA
|
+$105M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$47.9M |
| 3 |
Kroger
KR
|
+$42.8M |
| 4 |
Bread Financial
BFH
|
+$42.8M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$42.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.95B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.1B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$907M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$47.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.47% |
| 2 | Financials | 2.86% |
| 3 | Energy | 2.75% |
| 4 | Industrials | 1.72% |
| 5 | Healthcare | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Hormel Foods
HRL
$13.8B
| $394K | ﹤0.01% |
+9,718
| New | +$394K |
|
277
New York Times
NYT
$10.2B
| $392K | ﹤0.01% |
12,021
-7,345
| -38% | -$245K |
|
278
Crown Holdings
CCK
$13.1B
| $389K | ﹤0.01% |
6,364
-7,628
| -55% | -$445K |
|
279
Knowles
KN
$3.34B
| $387K | ﹤0.01% |
+21,114
| New | +$372K |
|
280
Pan American Silver
PAAS
$21.6B
| $376K | ﹤0.01% |
+29,151
| New | +$351K |
|
281
Newell Brands
NWL
$2.56B
| $371K | ﹤0.01% |
24,078
-33,944
| -59% | -$508K |
|
282
Madison Square Garden
MSGS
$9.39B
| $370K | ﹤0.01% |
1,852
-850
| -31% | -$181K |
|
283
FMC
FMC
$1.33B
| $368K | ﹤0.01% |
4,433
-5,575
| -56% | -$437K |
|
|
VSM
284
DELISTED
Versum Materials, Inc.
VSM
| $368K | ﹤0.01% |
+7,132
| New | +$368K |
|
285
VF Corp
VFC
$5.89B
| $365K | ﹤0.01% |
4,177
-88,697
| -96% | -$7.64M |
|
|
WP
286
DELISTED
Worldpay, Inc.
WP
| $364K | ﹤0.01% |
2,968
-2,649
| -47% | -$314K |
|
287
Vulcan Materials
VMC
$36.9B
| $342K | ﹤0.01% |
2,494
-3,735
| -60% | -$477K |
|
288
Resideo Technologies
REZI
$3.95B
| $335K | ﹤0.01% |
+15,271
| New | +$323K |
|
289
HUTCHMED
HCM
$2.17B
| $328K | ﹤0.01% |
+14,929
| New | +$426K |
|
290
Brink's
BCO
$4.62B
| $324K | ﹤0.01% |
3,993
-7,175
| -64% | -$571K |
|
291
Wabtec
WAB
$49.3B
| $321K | ﹤0.01% |
4,478
-6,719
| -60% | -$476K |
|
|
NOAH
292
Noah Holdings
NOAH
$603M
| $305K | ﹤0.01% |
+7,173
| New | +$330K |
|
293
Factset
FDS
$10.2B
| $304K | ﹤0.01% |
+1,061
| New | +$294K |
|
294
Weibo
WB
$1.95B
| $300K | ﹤0.01% |
+6,899
| New | +$387K |
|
|
WUBA
295
DELISTED
58.com Inc
WUBA
| $300K | ﹤0.01% |
+4,830
| New | +$311K |
|
296
General Dynamics
GD
$106B
| $284K | ﹤0.01% |
1,560
-26,610
| -94% | -$4.58M |
|
297
iQIYI
IQ
$1.28B
| $278K | ﹤0.01% |
+13,439
| New | +$278K |
|
|
PVG
298
DELISTED
PRETIUM RESOURCES INC.
PVG
| $277K | ﹤0.01% |
27,672
-272
| -1% | -$2.31K |
|
299
Wyndham Hotels & Resorts
WH
$5.48B
| $259K | ﹤0.01% |
4,648
-12,119
| -72% | -$663K |
|
300
nVent Electric
NVT
$26.7B
| $246K | ﹤0.01% |
9,941
-21,292
| -68% | -$548K |
|
Similar funds
Ray Dalio's Q2 2019 Portfolio in Review
As of Q2 2019, Ray Dalio held 380 positions worth $12.8B, down 22% from $16.3B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Ray Dalio withdrew a net $3.62B in Q2 2019, closing 75 positions and reducing 91 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $47.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 2.1% a quarter earlier, followed by Financials and Energy.
Against the trend, Ray Dalio opened a new position in iShares China Large-Cap ETF worth $30.6M.
- Ray Dalio's largest Q2 2019 buy was iShares China Large-Cap ETF: 716,186 shares worth $30.6M.
- Ray Dalio added most to iShares MSCI India ETF in Q2 2019, an estimated $105M increase.
- Ray Dalio's biggest Q2 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.95B.
- Ray Dalio fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $47.2M.
- Ray Dalio's ten largest holdings make up 69% of its $12.8B portfolio in Q2 2019.
- Ray Dalio opened 77 new positions and closed 75 in Q2 2019.
- Ray Dalio's portfolio value fell 22% quarter-over-quarter to $12.8B.
Based on Bridgewater Associates's 13F filing for Q2 2019, filed 13 Aug 2019.